Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:organic group
go back to main search page
Accession:CHEBI:33247 term browser browse the term
Definition:Any substituent group or skeleton containing carbon.
Synonyms:related_synonym: organic groups


show annotations for term's descendants           Sort by:
 





Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 19792
    chemical entity 19791
      group 19698
        organic group 18508
          ->3)-beta-D-Galp-(1->3)-beta-D-GalpNAc-(1->4)-[alpha-Neup5Ac-(2->8)-alpha-Neup5Ac-(2->8)-alpha-Neup5Ac-(2->3)]-beta-D-Galp-yl group 0
          ->4)-alpha-D-GalNAc-(1->6)-alpha-D-GlcN-(1->4)-alpha-D-(1->3)-[alpha-D-GalN-(1->4)-alpha-D-GalA-(1->7)-alpha-LD-Hep-(1->7)]-[beta-D-Glc-(1->2)]-alpha-LD-Hep-(1->3)-[beta-D-Gal-(1->4)]-alpha-LD-Hep-(1->5)-alpha-Kdo 0
          ->4)-alpha-D-Galp-(1->4)-beta-D-Galp-(1->4)-beta-D-Glcp-yl group + 0
          ->8)-alpha-Neu5Ac-(2->3)-[beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4)]-beta-D-Gal-(1->4)-yl group + 11
          3-(acyloxy)acyl group 0
          3-oxo-Delta(4)-steroid group + 7939
          3-oxo-Delta(5)-steroid group 0
          3beta-hydroxy-Delta(5)-steroid group 0
          9-(2-O-methyl-alpha-L-rhamnosyloxy)nonanoylamino group 0
          N(6)-[H2N-NLFQVVHNSYNRPAYSPG-N-\{54-amino-7,10,18,21,29,32,40,43,51,54-decaoxo-3,14,25,36,47-pentakis-[5-(\{2-[alpha-L-Rhap-(1->3)-beta-D-GlcpO]ethyl\}sulfinyl)pentanoyl]-3,6,11,14,17,22,25,28,33,36,39,44,47,50-tetradecaazatetrapentacont-1-yl\}]adipamido group 0
          N(6)-[alpha-L-Rhap-(1->3)-beta-D-Glcp-yl]adipamido group 0
          P-\{alpha-D-GlcpNAc-(1->3)-[D-GroA-(2->1)]-alpha-D-GlcpNAc-6-yl\}-alpha-D-GlcpNAc-(1->3)-[D-GroA-(2->1)]-alpha-D-GlcpNAc-P-6-[CH2]5NHC(=O)[CH2]4C(=O)NHR group 0
          abasic DNA-protein cross-linked residue + 0
          acyl group + 17368
          allene core 0
          amino-acid residue + 9397
          beta-D-GalpNAc-(1->4)-[alpha-Neup5Gc-(2->3)]-beta-D-Galp-(1->4)-R group + 0
          beta-GalNAc-(1->4)-[alpha-Neu5Ac-(2->8)-alpha-Neu5Ac-(2->3)]-beta-Gal-(1->4)-R group + 0
          carbonothioylidene group 0
          cyclic organic group + 1829
          cycloalkadienyl group + 0
          glycosyl group + 1
          glycosyloxy group + 0
          hydrocarbylidyne group + 0
          monosaccharide residue + 0
          nucleoside residue + 121
          nucleotide residue + 135
          organic divalent group + 18501
          organic pentavalent group 0
          organic tetravalent group + 1
          organic trivalent group 0
          organic univalent group + 18086
          organotriphosphate group 0
          peptide residue + 0
          phosphocholine group 0
          polypeptide-derived cofactor + 0
          thioacyl group + 0
          trisaccharide residue + 0
Path 2
Term Annotations click to browse term
  CHEBI ontology 19792
    subatomic particle 19788
      composite particle 19788
        hadron 19788
          baryon 19788
            nucleon 19788
              atomic nucleus 19788
                atom 19788
                  main group element atom 19675
                    p-block element atom 19675
                      carbon group element atom 19571
                        carbon group molecular entity 19571
                          organic molecular entity 19560
                            organic group 18508
                              ->3)-beta-D-Galp-(1->3)-beta-D-GalpNAc-(1->4)-[alpha-Neup5Ac-(2->8)-alpha-Neup5Ac-(2->8)-alpha-Neup5Ac-(2->3)]-beta-D-Galp-yl group 0
                              ->4)-alpha-D-GalNAc-(1->6)-alpha-D-GlcN-(1->4)-alpha-D-(1->3)-[alpha-D-GalN-(1->4)-alpha-D-GalA-(1->7)-alpha-LD-Hep-(1->7)]-[beta-D-Glc-(1->2)]-alpha-LD-Hep-(1->3)-[beta-D-Gal-(1->4)]-alpha-LD-Hep-(1->5)-alpha-Kdo 0
                              ->4)-alpha-D-Galp-(1->4)-beta-D-Galp-(1->4)-beta-D-Glcp-yl group + 0
                              ->8)-alpha-Neu5Ac-(2->3)-[beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4)]-beta-D-Gal-(1->4)-yl group + 11
                              3-(acyloxy)acyl group 0
                              3-oxo-Delta(4)-steroid group + 7939
                              3-oxo-Delta(5)-steroid group 0
                              3beta-hydroxy-Delta(5)-steroid group 0
                              9-(2-O-methyl-alpha-L-rhamnosyloxy)nonanoylamino group 0
                              N(6)-[H2N-NLFQVVHNSYNRPAYSPG-N-\{54-amino-7,10,18,21,29,32,40,43,51,54-decaoxo-3,14,25,36,47-pentakis-[5-(\{2-[alpha-L-Rhap-(1->3)-beta-D-GlcpO]ethyl\}sulfinyl)pentanoyl]-3,6,11,14,17,22,25,28,33,36,39,44,47,50-tetradecaazatetrapentacont-1-yl\}]adipamido group 0
                              N(6)-[alpha-L-Rhap-(1->3)-beta-D-Glcp-yl]adipamido group 0
                              P-\{alpha-D-GlcpNAc-(1->3)-[D-GroA-(2->1)]-alpha-D-GlcpNAc-6-yl\}-alpha-D-GlcpNAc-(1->3)-[D-GroA-(2->1)]-alpha-D-GlcpNAc-P-6-[CH2]5NHC(=O)[CH2]4C(=O)NHR group 0
                              abasic DNA-protein cross-linked residue + 0
                              acyl group + 17368
                              allene core 0
                              amino-acid residue + 9397
                              beta-D-GalpNAc-(1->4)-[alpha-Neup5Gc-(2->3)]-beta-D-Galp-(1->4)-R group + 0
                              beta-GalNAc-(1->4)-[alpha-Neu5Ac-(2->8)-alpha-Neu5Ac-(2->3)]-beta-Gal-(1->4)-R group + 0
                              carbonothioylidene group 0
                              cyclic organic group + 1829
                              cycloalkadienyl group + 0
                              glycosyl group + 1
                              glycosyloxy group + 0
                              hydrocarbylidyne group + 0
                              monosaccharide residue + 0
                              nucleoside residue + 121
                              nucleotide residue + 135
                              organic divalent group + 18501
                              organic pentavalent group 0
                              organic tetravalent group + 1
                              organic trivalent group 0
                              organic univalent group + 18086
                              organotriphosphate group 0
                              peptide residue + 0
                              phosphocholine group 0
                              polypeptide-derived cofactor + 0
                              thioacyl group + 0
                              trisaccharide residue + 0
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.